Clinical Trials Browser

Breast Carcinoma In Situ × Probiotics × 1 year × Clear all

NCT07044310 2025-07-29

5-strain Probiotic Formulation in HR-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss

Phase 2 Recruiting

Breast Carcinoma In Situ